Welcome to the Wyoming Chapter of the American College of Cardiology
Please join your cardiology colleagues at the ACC Rockies Chapter Meeting in Park City, Utah for updates on ACC affairs, the potential new CV Board, and clinical topics such as Genetic and Sports EP, plus a discussion on the growing role of obesity medications in heart failure, and the first-ever Cardiology State-of-the-State report. There will be many opportunities for networking, as well!. For more information and to register, please visit:
ACC Rockies Chapter Meeting 2025
|
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Latest in Cardiology from ACC.org
- Substantial Hospital-Level Variation in Immediate Coronary Angiography Among Patients With STEMI and OHCA | NCDR StudyAmong patients presenting with both out-of-hospital cardiac arrest (OHCA) and STEMI, substantial hospital-level variation was found in providing immediate coronary angiography (CA), according to a Brief Report published Feb. 11 in JACC.
- ACCEL Lite: VESALIUS-CV Trial: Effect of Evolocumab in Patients at CV Risk without Prior MI or StrokeIn this interview, Nanette Kass Wenger MD, MACC and Erin A. Bohula, MD, FACC discuss the VESALIUS-CV Trial: Effect of Evolocumab in Patients at CV Risk without Prior MI or Stroke.
- CORALreef Lipids: Oral PCSK9 Inhibitor Enlicitide Reduces LDL-C in High-Risk PatientsEnlicitide decanoate, an oral PCSK9 inhibitor, significantly reduced LDL-C levels in patients with a history of or at risk for a first atherosclerotic cardiovascular disease (ASCVD) event, according to results of the CORALreef Lipids trial published Feb. 4 in the NEJM.
- To β or Not to β? Insights From the BETAMI-DANBLOCK TrialThe BETAMI-DANBLOCK (Beta-Blockers after Myocardial Infarction in Patients without Heart Failure) trial results demonstrated that, in patients with recent type 1 or type 2 myocardial infarction (MI) and left ventricular ejection fraction (LVEF) ≥40%...
- Noninvasive Predictors of LA Compliance Post TMVTIn patients with severe mitral regurgitation (MR), low left atrial (LA) reservoir strain (LASr) and prior atrial fibrillation (AFib) intervention or LA appendage (LAA) ligation may predict low invasive LA compliance and limited V-wave reduction after transcatheter mitral valve therapy (TMVT)...